XML 132 R20.htm IDEA: XBRL DOCUMENT v3.2.0.727
Long-Term Debt
6 Months Ended
Jun. 30, 2015
Long-term Debt, Unclassified [Abstract]  
Long-term Debt [Text Block]
Long-term Debt
The following table presents the composition of our long-term debt portfolio.
 
 
June 30, 2015
 
December 31, 2014
($ in millions)
 
Unsecured
 
Secured
 
Total
 
Unsecured
 
Secured
 
Total
Long-term debt
 
 
 
 
 
 
 
 
 
 
 
 
Due within one year
 
$
465

 
$
11,540

 
$
12,005

 
$
4,809

 
$
12,629

 
$
17,438

Due after one year (a)
 
18,778

 
34,745

 
53,523

 
17,154

 
31,514

 
48,668

Fair value adjustment (b)
 
324

 

 
324

 
452

 

 
452

Total long-term debt 
 
$
19,567

 
$
46,285

 
$
65,852

 
$
22,415

 
$
44,143

 
$
66,558

(a)
Includes $2.6 billion of trust preferred securities at both June 30, 2015, and December 31, 2014.
(b)
Represents the fair value adjustment associated with the application of hedge accounting on certain of our long-term unsecured debt positions. Refer to Note 20 for additional information.
The following table presents the scheduled remaining maturity of long-term debt, assuming no early redemptions will occur. The actual payment of secured debt may vary based on the payment activity of the related pledged assets.
Year ended December 31, ($ in millions)
 
2015
 
2016
 
2017
 
2018
 
2019
 
2020 and
thereafter
 
Fair value
adjustment
 
Total
Unsecured
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Long-term debt
 
$
34

 
$
1,934

 
$
4,398

 
$
2,931

 
$
1,625

 
$
9,737

 
$
324

 
$
20,983

Original issue discount
 
(33
)
 
(74
)
 
(86
)
 
(97
)
 
(34
)
 
(1,092
)
 

 
(1,416
)
Total unsecured
 
1

 
1,860

 
4,312

 
2,834

 
1,591

 
8,645

 
324

 
19,567

Secured
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Long-term debt
 
5,732

 
10,365

 
13,665

 
7,462

 
4,902

 
4,159

 

 
46,285

Total long-term debt
 
$
5,733

 
$
12,225

 
$
17,977

 
$
10,296

 
$
6,493


$
12,804


$
324


$
65,852


The following summarizes assets restricted as collateral for the payment of the related debt obligation primarily arising from securitization transactions accounted for as secured borrowings and repurchase agreements.
 
 
June 30, 2015
 
December 31, 2014
($ in millions)
 
Total
 
Ally Bank (a)
 
Total
 
Ally Bank (a)
Investment securities (b)
 
$
2,062

 
$

 
$
786

 
$
786

Mortgage assets held-for-investment and lending receivables
 
9,205

 
9,205

 
7,541

 
7,541

Consumer automotive finance receivables
 
34,148

 
9,095

 
33,438

 
11,263

Commercial automotive finance receivables
 
19,018

 
18,593

 
20,605

 
20,083

Investment in operating leases, net
 
7,648

 
4,517

 
6,820

 
4,672

Total assets restricted as collateral (c) (d)
 
$
72,081

 
$
41,410

 
$
69,190

 
$
44,345

Secured debt (e)
 
$
52,839

 
$
25,693

 
$
47,867

 
$
27,134

(a)
Ally Bank is a component of the total column.
(b)
The investment securities are restricted under repurchase agreements. Refer to Note 13 for information on the repurchase agreements.
(c)
Ally Bank has an advance agreement with the Federal Home Loan Bank of Pittsburgh (FHLB), and had assets pledged to secure borrowings that were restricted as collateral to the FHLB totaling $12.4 billion and $10.7 billion at June 30, 2015, and December 31, 2014, respectively. These assets were composed primarily of consumer mortgage finance receivables and loans, net. Ally Bank has access to the Federal Reserve Bank Discount Window. Ally Bank had assets pledged and restricted as collateral to the Federal Reserve Bank totaling $3.1 billion and $3.2 billion at June 30, 2015, and December 31, 2014, respectively. These assets were composed of consumer automotive finance receivables and loans, net and investment in operating leases, net. Availability under these programs is only for the operations of Ally Bank and cannot be used to fund the operations or liabilities of Ally or its subsidiaries.
(d)
Excludes restricted cash and cash reserves for securitization trusts recorded within other assets on the Condensed Consolidated Balance Sheet. Refer to Note 11 for additional information.
(e)
Includes $6.6 billion and $3.7 billion of short-term borrowings at June 30, 2015, and December 31, 2014, respectively.
Funding Facilities
We utilize both committed credit facilities and other collateralized funding vehicles. The amounts outstanding under our various funding facilities are included on our Condensed Consolidated Balance Sheet.
As of June 30, 2015, Ally Bank had exclusive access to $3.25 billion of funding capacity from a committed credit facility. Funding programs supported by the Federal Reserve and the FHLB, together with repurchase agreements, complement Ally Bank’s private collateralized funding vehicles.
The total capacity in our committed funding facilities is provided by banks and other financial institutions through private transactions. The committed secured funding facilities can be revolving in nature and allow for additional funding during the commitment period, or they can be amortizing and not allow for any further funding after the closing date. At June 30, 2015, $21.7 billion of our $22.4 billion of committed capacity was revolving. Our revolving facilities generally have an original tenor ranging from 364 days to two years. As of June 30, 2015, we had $17.9 billion of committed funding capacity from revolving facilities with a remaining tenor greater than 364 days.
Committed Funding Facilities
 
 
Outstanding
 
Unused capacity (a)
 
Total capacity
($ in millions)
 
June 30, 2015
 
December 31, 2014
 
June 30, 2015
 
December 31, 2014
 
June 30, 2015
 
December 31, 2014
Bank funding
 
 
 
 
 
 
 
 
 
 
 
 
Secured
 
$
3,015

 
$
3,250

 
$
235

 
$
250

 
$
3,250

 
$
3,500

Parent funding
 
 
 
 
 
 
 
 
 
 
 
 
Secured
 
18,062

 
15,030

 
1,060

 
3,425

 
19,122

 
18,455

Total committed facilities
 
$
21,077

 
$
18,280

 
$
1,295

 
$
3,675

 
$
22,372

 
$
21,955

(a)
Funding from committed secured facilities is available on request in the event excess collateral resides in certain facilities or is available to the extent incremental collateral is available and contributed to the facilities.